Steven Lin, MD
Enriched profileProfessor, Radiation Oncology; Director of Research, Thoracic Radiation Oncology · The University of Texas MD Anderson Cancer Center
Steven Lin is Professor, Radiation Oncology; Director of Research, Thoracic Radiation Oncology at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 778 publications with 20,260 citations (h-index 72); ClinicalTrials.gov lists 18 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Radiation Oncology profiles in the findmyKOL directory.
Data verified 7 Sept 2026
Overview
Updated 13 Oct 2026
Steven H. Lin, MD, PHD, is Professor, Radiation Oncology at The University of Texas MD Anderson Cancer Center. The public record shows 778 publications with 20,260 citations (h-index 72), centered on Esophageal Cancer Research and Treatment, Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations. It also documents an investigator role on 18 registered clinical trials, industry payments reported by 9 companies, 5 NIH-funded awards (2017–2026).
- Most recent indexed publication: 2026 · Cancer research
- Top research focus: Esophageal Cancer Research and Treatment
- 18 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 269.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Oct 2026
Listed as an investigator on 18 registered studies on ClinicalTrials.gov. The most recent:
- Universal Immunization to Fortify Immunotherapy Efficacy and Response
Sponsor: University of Florida
- 18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
Sponsor: M.D. Anderson Cancer Center
- 18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer
Sponsor: M.D. Anderson Cancer Center
Industry payments
Updated 13 Oct 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20254 payments
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- IBA Proton Therapy, Inc.Program year20251 payment
NIH funding
Updated 13 Oct 2026
5 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- TOWARD TRANSLATION OF NANOPHOTONIC SINGLE EXOSOME LIQUID BIOPSY FOR HEPATOCELLULAR CARCINOMA SCREENING AND DIAGNOSIS
University of Houston
FY2026$656,935R01CA316276 - Role of genomic and microenvironment factors in conferring acquired resistance to ferroptosis to chemoradiation in esophageal adenocarcinoma
University of Tx Md Anderson Can Ctr
FY2026$306,002U54CA274220 - Project 2: Radiation-Induced Lymphopenia: Understanding, Predictive Modeling and Developing Photon and Proton-Based Mitigation Strategies.
Massachusetts General Hospital
FY2025$558,368P01CA261669
Congress activity
Updated 13 Oct 2026
203 congress contributions (2005–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract 6611: Ferroptotic vulnerability in M1 and M2 macrophages is associated with adaptive radiation resistance in esophageal adenocarcinoma.
AACR Annual Meeting
AACR2026Co-author - Abstract 1832: Identifying GSK3b inhibitor as a radiation induced type I interferon stimulator in lung cancer
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 13 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk.
Antioxidants (Basel, Switzerland)
Review2025 - Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial.
Journal for immunotherapy of cancer
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01The role of ferroptosis in ionizing radiation-induced cell death and tumor suppressionArticle1,350 citations2020
- 02Integrating genomic features for non-invasive early lung cancer detectionArticle701 citations2020
- 03
- 04Neuropeptide SArticle517 citations2004
- 05
Network
Updated 13 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 13 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- Member
American Society for Radiation Oncology (ASTRO); American Society of Clinical Oncology (ASCO); International Association for the Study of Lung Cancer (IASLC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Secondary affiliations
appointments beyond the home institution- Joint/secondary appointment
Department of Experimental Radiation Oncology, MD Anderson Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →amportal.astro.org ↗ - Principal Investigator
Lin Laboratory, MD Anderson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗
Media & interviews
press, podcasts and appearances- Steven H. Lin
MD, PhD, on Esophageal Cancer: Proton Beam vs Intensity-Modulated Radiation Therapy
2019verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →targetedonc.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancernetwork.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH